X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Phyllis Jones of Covington & Burling, Orlando Richmond, Butler Snow

Four years ago, Boehringer Ingelheim agreed to pay roughly $650 million to settle claims that its blood thinner Pradaxa caused excessive bleeding. But when the pharmaceutical giant was hit with a new wave of Pradaxa suits, Boehringer changed course. This time, it decided to go to court and fight.

This premium content is locked for
Litigation Daily subscribers only.

*May exclude premium content
Already have an account?
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to groupsales@alm.com to learn more.

Robert Storace

Robert Storace covers legal trends, lawsuits and analysis for the Connecticut Law Tribune. Follow him on Twitter @RobertSCTLaw or reach him at 203-437-5950.

More from this author

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2018 ALM Media Properties, LLC. All Rights Reserved.